← Leaderboards
Thomas Berry Huffaker
University Of Utah
$130,416
Attributed
$130,416
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2014–17$50K$37.5K$25K$12.5K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$130,416 · 1
By mechanism
F30$130,416 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Utah
Same institution · by research overlap
- William L. Carroll$23,653,738
- Garold S Yost$9,784,075
- Susan L. Neuhausen$19,099,097
- Martha Or Marty L Slattery$38,713,014
- Trudy Gale Oliver$9,454,558
Others in their field
Top investigators on “Adverse Effects”
- James Dennis Neaton · Northwestern University$203,539,316
- John M Lachin · George Washington University$139,991,329
- Elizabeth A Thom · George Washington University$126,101,581
- David M Nathan · Massachusetts Institute Of Technology$120,651,895
- Constance Ann Benson · University Of California, San Diego$114,806,215
- Wafaa M. El-Sadr · Columbia University Health Sciences$102,102,044
Research focus
Adverse EffectsImmuneAffectCancer CellHuman DiseaseHourCancer TherapyBone MarrowCarcinogensCause Of DeathCancer Immunology ScienceAlternative TreatmentCancer PatientCombatCommunitiesEmotionalEquilibriumFightingGene Expression RegulationGeneticGenetic ModelsGrowthHepatitis CImmune Response
Grant awards (4)
Immunological function and potential role of microRNA as a novel cancer treatment$49,044
F30 · FY2017 · CA · contact PI
Immunological function and potential role of microRNA as a novel cancer treatment$27,576
F30 · FY2016 · CA · contact PI
Immunological function and potential role of microRNA as a novel cancer treatment$27,120
F30 · FY2015 · CA · contact PI
Immunological function and potential role of microRNA as a novel cancer treatment$26,676
F30 · FY2014 · CA · contact PI